30 closest matches · ranked by relevance
Abdominal Neoplasms
Primary: Capability of Performing EUS-FNTA Through the Duodenum by Placing the Target Lesion in the Proper Position With Insertion of the Needle Into the Lesion — 228 Participants
Pancreatic Cancer · Lymphadenopathy · Gastrointestinal Stromal Tumor
Primary: Diagnostic Yield of EUS-FNB and EUS-FNA — 67.1; 90 percentage of patients
Non-alcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis
Primary: Median Total Specimen Length — 8; 14; 8; 11.5 mm
Pancreatic Cancer
Primary: Total DNA Yield of Adenocarcinoma — 5930.10; 3365.22 ng/µL — p=0.01
Biopsy, Fine-Needle · Biopsy, Fine-Needle/Methods · Endosonography
Primary: Compare Adequacy of Diagnoses in Passes With and Without a Stylet — 80; 68; 21; 18 passes
Pancreatic Masses · Lymph Nodes
Primary: Diagnostic Accuracy — 237; 263 Participants
GIST
Primary: Diagnostic Accuracy. — 88; 62 Percentage of participants
Pancreatic Neoplasm
Primary: Diagnostic Accuracy — 84 Diagnostic accuracy (%)
EUS Guided Biopsy
Primary: Is the Acquire Needle Non-inferior Compared to SharkCore Needle in Histologic Yield of the Sample Obtained? — 3; 4; 10; 14 Lesions
Obesity · Non-Alcoholic Steatohepatitis
Primary: Weight Loss Achieved With Intragastric Balloon (IGB) — 17 Participants
Diagnoses Diseases · Ultrasound Therapy; Complications · Liver Diseases
Primary: Number of Specimens for Which a Histologic Diagnosis Could be Made Based Upon the Amount of Tissue Obtained With the Needle — 17; 14 specimens
Abnormal Liver Function
Primary: Pre-processing Length of the Longest Piece (LLP) — 1.47; 2.09 centimeter
Pancreatic Neoplasm
Primary: Compare the Median Number of Passes Required to Establish a Diagnosis — 1; 1 No. of passes for diagnosis
Pulmonary Disease
Primary: Time to Achieve Hemostasis After Obtaining Cryobiopsy — 146.55; 132.25 seconds — p=0.7878
Liver Diseases
Primary: Pathological Yield Fragmentation — 14; 11; 13; 10 mm
Pancreatic Solid Lesions · Pancreatic Mass
Primary: Diagnostic Yield of Capillary Technique — 75.4 percentage of specimen
Cancer of Pancreas · Pancreatic Neoplasm
Primary: Median Number of Passes to Establish Diagnosis — 1; 1 No. of passes
Cholangiopancreatography, Endoscopic Retrograde · Biliary Stricture · Biliary Tract Diseases
Primary: Performance Characteristics — 84.09; 56.98; 94.87 Percentage
Non Small Cell Lung Cancer · NSCLC
Primary: Feasibility of Utilizing Endobronchial Ultrasound Guided Miniforceps as Assessed by the Number of Participants From Whom Adequate Amounts of Tissue to Perform PD-L1…
Myopathy · Myositis · Muscular Dystrophy
Primary: Amount of Tissue Obtained — 0.29; 0.28 grams
Pulmonary Lesions · Pulmonary Nodules · Pulmonary Mass
Primary: Diagnostic Yield of Procedures; Number of Positive Diagnosis of Pulmonary Lesions — 51; 62; 58; 51 participants
Solid Pancreatic Mass Lesions · Malignant Neoplasm of Pancreas
Primary: Comparison of Diagnostic Adequacy Scores With SST vs. CST for Cytologic Diagnosis Using a 22G Core Needle. — 5; 6; 24; 24 Participants
Lung Nodule
Primary: Diagnostic Accuracy — 94; 81 Participants — p=0.003
Accuracy of Tissue Diagnosis · Bile Duct Stricture · Pancreatic Duct Stricture
Primary: Percentage of Participants With Accurate Diagnoses of Cancer — 38.5; 53.9; 84.6 percentage of accurate diagnoses
Barrett's Esophagus
Primary: Number of Subjects in Which the Targeted Locations Identified Through OFDI Imaging Correlates With the Biopsies. — 22 Participants
Hypermetabolic Lymphadenopathy Mediastinum Lower, Posterior and Middle, Detected by PET-CT With 18F-FDG (PET)
Primary: Sensitivity of Endoscopic Ultrasound-guided (EUS-guided) Puncture — 93 percentage
Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma · Lung Cancer
Primary: Percentage of Lymph Nodes With Adequate Samples — 79; 78.5 Percentage of Lymph Nodes
Pancreatic Cystic Lesions
Primary: Volume of Aspirated Cyst Fluid as a Function of Estimated Maximal Volume — 78; 74; 73 percentage of cyst volume aspirated — p=0.84
Crohn Disease · Rectal Fistula
Primary: Number of Participants With Durable Fistula Healing — 7; 8 participants
Bronchi--Diseases · Lung Diseases, Obstructive · Lesions Mass
Primary: Ability to Successfully Obtain Sample — 123; 130 tissue samples